{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:07:58Z","timestamp":1783649278502,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/December-2021\/PGTHESIS-HRD"],"award-info":[{"award-number":["3\/2\/December-2021\/PGTHESIS-HRD"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.psychres.2024.116257","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:59:26Z","timestamp":1731052766000},"page":"116257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial"],"prefix":"10.1016","volume":"342","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-1505","authenticated-orcid":false,"given":"Shampa","family":"Maji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-299X","authenticated-orcid":false,"given":"Archana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-744X","authenticated-orcid":false,"given":"Debadatta","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-0922","authenticated-orcid":false,"given":"Anand","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-9178","authenticated-orcid":false,"given":"Rituparna","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.116257_bib0001","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.psychres.2024.116257_bib0002","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-023-01032-5","article-title":"Dextromethorphan-bupropion for the treatment of depression: A systematic review of efficacy and safety in clinical trials","volume":"37","author":"Akbar","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2024.116257_bib0003","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clinthera.2011.11.024","article-title":"Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study","volume":"34","author":"Anderson","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.psychres.2024.116257_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027250","article-title":"Prevalence and socioeconomic impact of depressive disorders in India: Multisite population-based cross-sectional study","volume":"9","author":"Arvind","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2024.116257_bib0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/NDT.S185757","article-title":"Selective serotonin reuptake inhibitor-induced sexual dysfunction: Current management perspectives","volume":"16","author":"Atmaca","year":"2020","journal-title":"Neuropsychiatr Dis Treatm"},{"key":"10.1016\/j.psychres.2024.116257_bib0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0007","first-page":"169","article-title":"ON or OFF?: modulating the N-Methyl-d-Aspartate Receptor in Major Depression","volume":"9","author":"Chan","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.psychres.2024.116257_bib0008","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jat\/31.4.227","article-title":"Dextromethorphan in wisconsin drivers","volume":"31","author":"Cochems","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.psychres.2024.116257_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5414\/CPP38061","article-title":"Interethnic differences of drug-metabolizing enzymes","volume":"38","author":"Gaedigk","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2024.116257_bib0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1590\/1516-4446-2020-1543","article-title":"Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial","volume":"43","author":"Guimaraes","year":"2021","journal-title":"Braz J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-021-00816-x","article-title":"Novel glutamatergic modulators for the treatment of mood disorders: Current status","volume":"35","author":"Henter","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2024.116257_bib0012","doi-asserted-by":"crossref","first-page":"21m14345","DOI":"10.4088\/JCP.21m14345","article-title":"Efficacy and safety of AXS-05 (dextromethorphan-bupropion) in patients with major depressive disorder: A phase 3 randomized clinical trial (GEMINI)","volume":"83","author":"Iosifescu","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0013","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.mp.4001551","article-title":"Glutamate as a therapeutic target in psychiatric disorders","volume":"9","author":"Javitt","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0014","first-page":"605","article-title":"Selective Serotonin Re-uptake Inhibitors: an overview","volume":"30","author":"Joshi","year":"2018","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.psychres.2024.116257_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ijnp\/pyy094","article-title":"Glutamatergic neurotransmission: Pathway to developing novel rapid-acting antidepressant treatments","volume":"22","author":"Kadriu","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2024.116257_bib0016","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S1092852921000237","article-title":"Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view","volume":"27","author":"Kar","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2024.116257_bib0017","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40263-022-00968-4","article-title":"Dextromethorphan\/Bupropion: First approval","volume":"36","author":"Keam","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2024.116257_bib0018","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.psychres.2024.116257_bib0019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103637","article-title":"Bifrontal-transcranial direct current stimulation as an early augmentation strategy in major depressive disorder: a single-blind randomised controlled trial","volume":"86","author":"Kumari","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.psychres.2024.116257_bib0021","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40265-017-0702-8","article-title":"Ketamine and beyond: Investigations into the potential of glutamatergic agents to treat depression","volume":"77","author":"Lener","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2024.116257_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2007.09.017","article-title":"Simultaneous analysis of dextromethorphan and its three metabolites in human plasma using an improved HPLC method with fluorometric detection","volume":"859","author":"Lin","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.psychres.2024.116257_bib0023","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/FBP.0000000000000649","article-title":"Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats","volume":"32","author":"Lynch","year":"2021","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116257_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.12.001","article-title":"New targets for rapid antidepressant action","volume":"152","author":"Machado-Vieira","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.psychres.2024.116257_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080500","article-title":"Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled clinical trial protocol","volume":"14","author":"Maji","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2024.116257_bib0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.9758\/cpn.23.1081","article-title":"Dextromethorphan-bupropion (Auvelity) for the treatment of major depressive disorder","volume":"21","author":"McCarthy","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.psychres.2024.116257_bib0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/1735-5362.297847","article-title":"Dextromethorphan improved cyclosporine-induced depression in mice model of despair","volume":"15","author":"Mesripour","year":"2020","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.psychres.2024.116257_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)","volume":"77","author":"Muller","year":"2003","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psychres.2024.116257_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2017.04.072","article-title":"Dextromethorphan\/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial","volume":"218","author":"Murrough","year":"2017","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psychres.2024.116257_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2015.03.024","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice","volume":"295","author":"Nguyen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2024.116257_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pbb.2017.09.005","article-title":"Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice","volume":"161","author":"Nguyen","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2024.116257_bib0031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expert Opin. Drug Saf"},{"key":"10.1016\/j.psychres.2024.116257_bib0032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0897190012467210","article-title":"Guidance for the discontinuation or switching of antidepressant therapies in adults","volume":"26","author":"Ogle","year":"2013","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.psychres.2024.116257_bib0033","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jpsychires.2010.03.006","article-title":"Response and remission criteria in major depression\u2013a validation of current practice","volume":"44","author":"Riedel","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2024.116257_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173003","article-title":"Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice","volume":"197","author":"Saavedra","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2024.116257_bib0035","first-page":"e2652","article-title":"A review of the mechanism of antagonism of n-methyl-d-aspartate receptor by ketamine in treatment-resistant depression","volume":"10","author":"Sattar","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.psychres.2024.116257_bib0036","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1527-3458.2007.00006.x","article-title":"Dextromethorphan: A review of N-methyl-d-aspartate receptor antagonist in the management of pain","volume":"13","author":"Siu","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.psychres.2024.116257_bib0037","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1192\/bjp.148.5.599","article-title":"Grade scores of the montgomery-asberg depression and the clinical anxiety scales","volume":"148","author":"Snaith","year":"1986","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.psychres.2024.116257_bib0038","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1092852919001470","article-title":"Dextromethorphan\/bupropion: A novel Oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity","volume":"24","author":"Stahl","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2024.116257_bib0039","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.21080800","article-title":"Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: A randomized double-blind controlled trial","volume":"179","author":"Tabuteau","year":"2022","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.psychres.2024.116257_bib0040","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.psychres.2024.116257_bib0042","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1002\/mco2.156","article-title":"The molecular pathophysiology of depression and the new therapeutics","volume":"3","author":"Tian","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.psychres.2024.116257_bib0043","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.psychres.2024.116257_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116257_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105761","article-title":"Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression","volume":"171","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2024.116257_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28817","article-title":"Esketamine vs midazolam in boosting the efficacy of oral antidepressants for major depressive disorder: A pilot randomized clinical trial","volume":"6","author":"Xiao","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.psychres.2024.116257_bib0047","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","article-title":"Molecular basis of ethnic differences in drug disposition and response","volume":"41","author":"Xie","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.psychres.2024.116257_bib0048","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116257_bib0049","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124005420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124005420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:36:21Z","timestamp":1777494981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124005420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"alternative-id":["S0165178124005420"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116257","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116257"}}